24Hour Journal · Jul 29, 2026

The Deal-Risk Discount: Tranching a $10,000 Allocation into Precision Oncology's MRD Land Grab

0Sign in to vote or save

This site does not allow itself to be embedded. You can still read it on the original site — the toolbar below keeps your place in the directory.

Tempus AI is down 31% on a merger scare four days before earnings — the self-directed case for waiting on clarity, not chasing the panic.

Subscribe now

If you are reacting to market conditions, you are already late. Everyone watching Tempus AI () right now is reacting to a single ugly chart: a stock that was in the mid-$50s two weeks ago and closed Friday at $42.69. What almost nobody’s pricing correctly is the forward-looking transition underneath that chart — a company that just paid $1.5 billion to …

Read on 24hourjournal.substack.com ↗

Comments

Nothing yet. Say the first thing.